• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic research for clinical treatment of neuropathic Gaucher disease by chemical chhaperones

Research Project

Project/Area Number 20390297
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionTottori University

Principal Investigator

OHNO Kousaku  Tottori University, 医学部, 教授 (70112109)

Co-Investigator(Renkei-kenkyūsha) SUGIURA Titose  鳥取大学, 医学部・附属病院, 講師 (90325027)
INOUE Takehiko  鳥取大学, 医学部・附属病院, 助教 (80346361)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000)
Fiscal Year 2010: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2009: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2008: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
Keywordsゴーシェ病 / シャペロン / 経口治療薬 / モデルマウス / リソゾーム
Research Abstract

There are no effective treatment for neurological manifestations in Gaucher disease. We found N-octyl-β-valienamine (NOV) could increase the protein level and enzyme activity of F213I mutant GBA in culture cells. We have tried to establish a model mouse expressing F213I protein, but failed to establish the mice. The NOV effects on normal mice were evaluated. No adverse effect was observed and GBA activity increased with increasing NOV dose in tissues. We also found new compounds, bicyclic nojirimycin analogues, show a chemical chaperone activity on mutant GBAs.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (30 results)

All 2011 2010 2009 2008 Other

All Journal Article (19 results) (of which Peer Reviewed: 17 results) Presentation (9 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 2 results)

  • [Journal Article] Chemical chaperone therapy : chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency.2011

    • Author(s)
      Higaki K, Li L, Udin Bahrudin, Okuzawa S, Takamura A, Yamamoto K, Adachi K, Rubigilda C. Paraguison, Takai T, Ikehata H, Tominaga L, Hisatome I, Iida M, Ogawa S, Matsuda J, Ninomiya H, Sakakibara Y, Ohno K, Suzuki Y, Nanba E.
    • Journal Title

      Human Mutation. in press

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The effect of N-octyl-β-valienamine on β-glucosidase activity in tissues of normal mice.2010

    • Author(s)
      Luan Z, Ninomiya H, Ohno K, Ogawa S, Kubo T, Iida M, Suzuki Y.
    • Journal Title

      Brain Dev 32(10)

      Pages: 805-809

    • NAID

      10029559648

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] A fluorescent SP2-iminosugar with pharmacological chaperone activity for Gaucher disease : Cellular uptake and intracellular distribution studies.2010

    • Author(s)
      Luan Z, Higaki K, Aguilar-Moncayo M, Li L, Ninomiya H, Nanba E, Ohno K, Garcia-Moreno M, Mellet CO, Fernandez JMG, Suzuki Y.
    • Journal Title

      ChemBioChem 11(17)

      Pages: 2453-2464

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Chemical chaperone therapy : Luciferase assay for screening of b-galactosidase mutations.2010

    • Author(s)
      Li L, Higaki K, Ninomiya H, Luan Z, Iida M, Ogawa S, Suzuki Y, Nanba E, Ohno K.
    • Journal Title

      Mol Genet Metab 101(4)

      Pages: 364-369

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases.2010

    • Author(s)
      Luan Z, Li L, Ninomiya H, Ohno K, Ogawa S, Kubo T, Iida M, Suzuki Y.
    • Journal Title

      Blood Cells Mot Dis. 44(1)

      Pages: 48-54

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] ライソゾーム病の治療シャペロン療法2010

    • Author(s)
      大野耕策
    • Journal Title

      血液フロンティア 20(4)

      Pages: 69-77

    • Related Report
      2010 Final Research Report
  • [Journal Article] The effect of N-octyl-β-valienamine on β-glucosidase activity in tissues of normal mice2010

    • Author(s)
      Luau Z
    • Journal Title

      Brain Dev

      Volume: 32 Pages: 805-809

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A fluorescent SP2-iminosugar with pharmacological chaperone activity for Gaucher disease : Cellular uptake and intracellular distribution studies2010

    • Author(s)
      Luan Z
    • Journal Title

      ChemBioChem

      Volume: 11 Pages: 2453-2464

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Chemical chaperone therapy : Luciferase assay for screening of b-galactosidase mutations2010

    • Author(s)
      Li L
    • Journal Title

      Mol Genet Metab

      Volume: 101 Pages: 364-369

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases2010

    • Author(s)
      Luan Z
    • Journal Title

      Blood Cells Mol Dis

      Volume: 44 Pages: 48-54

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The pharmacological chaperone effect of N-octyl-beta-vallienamine on human mutant acid beta-glucosidases2010

    • Author(s)
      Luan Z
    • Journal Title

      Blood Cells Mol Dis 44

      Pages: 48-54

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ライソゾーム病の治療 シャペロン療法2010

    • Author(s)
      大野耕策
    • Journal Title

      血液フロンティア 20

      Pages: 69-77

    • Related Report
      2009 Annual Research Report
  • [Journal Article] Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.2009

    • Author(s)
      Luan Z, Higaki K, Aguilar-Moncayo M, Ninomiya H, Ohno K, Garcia-Moreno MI, Ortiz Mellet C, Garcia Fernandez JM, Suzuki Y.
    • Journal Title

      Chembiochem. 10(17)

      Pages: 2780-2792

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin2009

    • Author(s)
      Luan Z
    • Journal Title

      Chembiochem 10

      Pages: 2780-2792

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Brainstem neuropathology in a mouse model of Niemann-Pick disease type C.2008

    • Author(s)
      Luan Z, Saito Y, Miyata H, Ohama E, Ninomiya H, Ohno K.
    • Journal Title

      J Neurol Sci. 268(1-2)

      Pages: 108-116

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis.2008

    • Author(s)
      Takamura A, Higaki K, Kajimaki K, Otsuka S, Ninomiya H, Matsuda J, Ohno K, Suzuki Y, Nanba E.
    • Journal Title

      Biochem Biophys Res Commun. 367(3)

      Pages: 616-622

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Brainstem neuropathology in a mouse model of Niemann-Pick disease type C.2008

    • Author(s)
      Luan Z, Saito Y, Miyata H, Ohama E, Ninomiya H, Ohno K.
    • Journal Title

      J Neurol Sci 268

      Pages: 108-116

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis.2008

    • Author(s)
      Takamura A, Bigaki K, Kajimaki K, Otsuka S, Ninomiya H, Natsuda J, Ohno K, Suzuki Y, Nanba E.
    • Journal Title

      Biochem Biophys Res Commun 367

      Pages: 616-622

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Chemical chaperone therapy : chaperone effect on mutant enzyme and cellular pathophysiology in β -galactosidase deficiency

    • Author(s)
      Higaki K
    • Journal Title

      Human Mutation

      Volume: (in press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] 遺伝性小児神経疾患の治療について2011

    • Author(s)
      大野耕策
    • Organizer
      第1回由布院・児湯小児神経学研究会
    • Place of Presentation
      大分
    • Year and Date
      2011-03-18
    • Related Report
      2010 Final Research Report
  • [Presentation] ライソゾーム病の新しい低分子治療薬の開発2010

    • Author(s)
      大野耕策
    • Organizer
      第15回日本ライソゾーム病研究会
    • Place of Presentation
      東京
    • Year and Date
      2010-12-11
    • Related Report
      2010 Final Research Report
  • [Presentation] 医師とともに治療する薬剤業務-遺伝性ライソゾーム病に対する新しい治療と薬剤部との連携-2010

    • Author(s)
      大野耕策
    • Organizer
      第49回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会
    • Place of Presentation
      米子
    • Year and Date
      2010-11-06
    • Related Report
      2010 Final Research Report
  • [Presentation] 神経変性疾患と先天代謝異常症2010

    • Author(s)
      大野耕策
    • Organizer
      第52回日本先天代謝異常学会
    • Place of Presentation
      大阪
    • Year and Date
      2010-10-23
    • Related Report
      2010 Final Research Report
  • [Presentation] Molecular pathology : Gaucherdisease2010

    • Author(s)
      大野耕策
    • Organizer
      シャペロン療法国際シンポジウム
    • Place of Presentation
      米子
    • Year and Date
      2010-07-29
    • Related Report
      2010 Final Research Report
  • [Presentation] Chemical chaperone for Gaucher disease2010

    • Author(s)
      大野耕策
    • Organizer
      第1回アジア先天代謝異常学会議(The 1st ACIMD)
    • Place of Presentation
      福岡
    • Year and Date
      2010-03-09
    • Related Report
      2010 Final Research Report
  • [Presentation] リソゾーム病の新しい治療を中心に2009

    • Author(s)
      大野耕策
    • Organizer
      第4回成育代謝異常症研究会
    • Place of Presentation
      東京
    • Year and Date
      2009-12-04
    • Related Report
      2010 Final Research Report
  • [Presentation] ゴーシェ病へのケミカルシャペロン療法2009

    • Author(s)
      大野耕策
    • Organizer
      第1回カプアセミナー
    • Place of Presentation
      千葉
    • Year and Date
      2009-08-22
    • Related Report
      2010 Final Research Report
  • [Presentation] 遺伝性神経疾患の神経変性機構の解明と治療法の開発2009

    • Author(s)
      大野耕策
    • Organizer
      第51回日本小児神経学会総会 会長講演
    • Place of Presentation
      米子
    • Year and Date
      2009-05-28
    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] Carba-sugar amine derivativeand glycolipid metabolic disorder treating agent containing the same as active agent2010

    • Inventor(s)
      Ogawa S, SuzukiY, Nanba E, MatsudaJm Ohno K
    • Industrial Property Rights Holder
      生化学工業
    • Acquisition Date
      2010-05-25
    • Related Report
      2010 Final Research Report
    • Overseas
  • [Patent(Industrial Property Rights)] Compuestos potenciadores de la actividad de glicosidasas mutantes2009

    • Inventor(s)
      Jose Manuel Garcia Fernandez, Carmen Ortiz Mellet, Yoshiyuki Suzuki, Kousaku Ohno
    • Industrial Property Rights Holder
      鳥取大学、国際医療福祉大学、スペイン・セビリア大学
    • Acquisition Date
      2009-11-05
    • Related Report
      2010 Final Research Report
    • Overseas

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi